Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 6/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.46 |
| ▸ | TP53BP1 | Q12888 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 1/20 | 0.45 |
| ▸ | RXRB | P28702 | 1/20 | 0.45 |
| ▸ | RXRG | P48443 | 1/20 | 0.45 |
| ▸ | USP5 | P45974 | 1/20 | 0.45 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 6/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | MDM4 | O15151 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10172211 | 0.90 | HSD17B3 (0.49) | L3MBTL1HSD17B3TP53BP1RXRARXRB | |
| SCHEMBL4227994 | 0.86 | TP53BP1 (0.48) | HPGDSMN1; SMN2L3MBTL1TP53BP1RXRA | |
| SCHEMBL29153730 | 0.83 | HSD17B3 (0.57) | HPGDSMN1; SMN2L3MBTL1HSD17B3MAPT | |
| SCHEMBL6580274 | 0.82 | TP53BP1 (0.48) | HPGDSMN1; SMN2TP53BP1RXRARXRB | |
| SCHEMBL10447489 | 0.81 | MMP1 (0.48) | HPGDSMN1; SMN2TP53BP1USP5KAT6A | |
| SCHEMBL18552569 | 0.81 | TP53BP1 (0.47) | HPGDSMN1; SMN2TP53BP1RXRARXRB | |
| SCHEMBL11744047 | 0.81 | GSK3B (0.52) | HPGDSMN1; SMN2TP53BP1RXRARXRB | |
| SCHEMBL4595838 | 0.79 | MAPT (0.59) | HPGDSMN1; SMN2TP53BP1RXRARXRB | |
| SCHEMBL15761188 | 0.79 | HTR7 (0.50) | SMN1; SMN2L3MBTL1HSD17B3MAPTKDM4E | |
| SCHEMBL11698417 | 0.79 | TDP1 (0.64) | HPGDSMN1; SMN2L3MBTL1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4021900-B1 | 2,2,6-TRIMETHYL-4,5-DIHYDRO-3H-OXEPINE AS AROMA INGREDIENT | BASF SE (DE) | 2023-10-11 | — | — | EP | claimed |
| EP-4096618-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2022-12-07 | — | — | EP | claimed |
| US-20220281834-A1 | 2,2,6-TRIMETHYL-4,5-DIHYDRO-3H-OXEPINE AS AROMA INGREDIENT | BASF SE (DE) | 2022-09-08 | — | — | US | claimed |
| EP-4021900-A1 | 2,2,6-TRIMETHYL-4,5-DIHYDRO-3H-OXEPINE AS AROMA INGREDIENT | BASF SE (DE) | 2022-07-06 | — | — | EP | claimed |
| WO-2022122143-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| WO-2021037806-A1 | 2,2,6-TRIMETHYL-4,5-DIHYDRO-3H-OXEPINE AS AROMA INGREDIENT | BASF SE (DE) | 2021-03-04 | — | — | WO | claimed |
| US-20240301331-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-09-12 | — | — | US | disclosed |
| CN-114096283-B | Method of atomizing a fluid composition | 宝洁公司 | 2024-04-16 | — | — | CN | disclosed |
| EP-4294906-A1 | IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-12-27 | — | — | EP | disclosed |
| US-11760960-B2 | Solid fragrance-containing composition with an inorganic/organic rheology modifier mixture | HENKEL AG & CO. KGAA (DE) | 2023-09-19 | — | — | US | disclosed |
| WO-2022175314-A1 | IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-08-25 | — | — | WO | disclosed |
| CN-109476570-B | 6-isopropyl-2, 4-dimethylcyclohexen-1-ol compounds as fragrance ingredients | 奇华顿股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| US-20200255769-A1 | Solid Fragrance-Containing Composition | HENKEL AG & CO. KGAA (DE) | 2020-08-13 | — | — | US | disclosed |
| US-20170355697-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | GLAXOSMITHKLINE LLC | 2017-12-14 | — | — | US | disclosed |
| EP-2799864-A1 | Method to evaluate fragrance compositions | The Procter and Gamble Company (US) | 2014-11-05 | — | — | EP | disclosed |
| EP-2799863-A1 | Method to evaluate fragrance compositions | The Procter and Gamble Company (US) | 2014-11-05 | — | — | EP | disclosed |
| EP-1385470-A1 | FRAGRANT MIXTURES WITH INCREASED STRENGTH OF ODOR | Symrise GmbH & Co. KG (DE) | 2004-02-04 | — | — | EP | disclosed |
| WO-2002076421-A1 | FRAGRANT MIXTURES WITH INCREASED STRENGTH OF ODOR | SYMRISE GMBH & CO. KG (DE) | 2002-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170355697-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | SIRT1, SIRT3, SIRT2 | HPGD 302/4885SMN1; SMN2 2122/4885L3MBTL1 2574/4885 |
| US-20220281834-A1 | 2,2,6-TRIMETHYL-4,5-DIHYDRO-3H-OXEPINE AS AROMA INGREDIENT | DRD4, HTR5A, HTR4 | HPGD 985/4885SMN1; SMN2 2116/4885L3MBTL1 3128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.